Farther Finance Advisors »

Novabay Pharmaceuticals shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Novabay Pharmaceuticals (SDEV) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1 1 1.00

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Vanguard Value Etf Etf (VTV)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)

View all positions for Farther Finance Advisors

Top funds holding Novabay Pharmaceuticals

BlackRock
Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Jane Street
State Street Corporation
Renaissance Technologies
Northern Trust
Qube Research & Technologies
Two Sigma Investments
State of Wyoming
Schonfeld Strategic Advisors
Catalyst Funds Management Pty
Hrt Financial
Vanguard Global Advisers

View all funds holding Novabay Pharmaceuticals